Tirzepatide News | Live Feed & Top Stories - 星空传媒

Tirzepatide

In the last 4 hours

News-Medical.Net20:29

In the last 6 hours

Study Finds19:21

American Journal of Managed Care18:08

In the last 8 hours

BioWorld17:30

Proactive Investors (US)16:14

Medpage Today16:00

Earlier today

American Journal of Managed Care15:26

Proactive Investors (US)15:03

Drug Topics14:55

UNILAD14:53

Kuwait Times14:30

People14:01

Miami Herald12:59

TCTMD12:40

Business Wire (Press Release)12:03

TIME11:26

CBS News11:11

News-Medical.Net11:09

Proactive Investors (US)10:48

The Week10:44

Tyla09:47

Quartz09:41

LADbible09:09

Business Wire (Press Release)08:01

Tyla07:18

Greek Reporter07:14

Daily Record07:01

MailOnline06:44

Sky News06:37

Manchester Evening News06:28

pharmaphorum06:15

pharmaphorum05:44

Yahoo! UK & Ireland05:37

Manchester Evening News05:36

New Food05:23

LADbible05:19

AniNews.in04:55

Evening Standard04:36

PR Newswire (Press Release)03:02

Yesterday

BBC20:13 11-May-25

LBC News19:16 11-May-25

i News18:12 11-May-25

MailOnline18:12 11-May-25

The Mirror18:10 11-May-25

Yahoo! UK & Ireland18:02 11-May-25

PR Newswire (Press Release)18:02 11-May-25

Yorkshire Post08:59 11-May-25

In the last 7 days

Live Science12:39 10-May-25

American Journal of Managed Care18:47 9-May-25

American Journal of Managed Care10:38 9-May-25

American Journal of Managed Care10:17 9-May-25

American Journal of Managed Care09:16 9-May-25

Welsh Government (Press Release)06:53 9-May-25

The Actuary05:33 9-May-25

Belfast Live03:33 9-May-25

American Journal of Managed Care16:10 8-May-25

American Journal of Managed Care11:24 8-May-25

Bloomberg Law09:38 8-May-25

Medpage Today09:38 8-May-25

American Journal of Managed Care09:11 8-May-25

Welsh Government (Press Release)08:09 8-May-25

PR Newswire (Press Release)06:50 8-May-25

ParentData05:09 8-May-25

The Motley Fool05:00 8-May-25

American Journal of Managed Care17:35 7-May-25

Pharmacy Times16:09 7-May-25

American Journal of Managed Care14:22 7-May-25

ENDPOINTS12:40 7-May-25

PinkNews.co.uk12:05 7-May-25

Zacks11:31 7-May-25

Benzinga09:20 7-May-25

American Journal of Managed Care09:17 7-May-25

Invezz08:52 7-May-25

The Independent01:18 7-May-25

Newswise (Press Release)18:04 6-May-25

WDAM15:55 6-May-25

American Journal of Managed Care13:46 6-May-25

Medpage Today13:30 6-May-25

American Journal of Managed Care12:25 6-May-25

American Journal of Managed Care10:43 6-May-25

Business Wire (Press Release)10:08 6-May-25

The Motley Fool10:04 6-May-25

American Journal of Managed Care10:02 6-May-25

American Journal of Managed Care09:32 6-May-25

American Journal of Managed Care09:22 6-May-25

Forbes08:57 6-May-25

NutraIngredients.com07:16 6-May-25

Technology Networks05:29 6-May-25

Rock Hill Herald21:31 5-May-25

American Journal of Managed Care17:16 5-May-25

The Nittany Turkey (Weblog)16:17 5-May-25

Newswise (Press Release)15:27 5-May-25

American Journal of Managed Care12:52 5-May-25

i News10:51 5-May-25

American Journal of Managed Care09:27 5-May-25

In the last month

Fox News14:40 4-May-25

LADbible07:33 3-May-25

Hindustan Times07:00 3-May-25

Knowridge Science Report20:34 2-May-25

American Journal of Managed Care16:11 2-May-25

Simply Wall St15:35 2-May-25

The Daily Caller15:09 2-May-25

Benzinga14:58 2-May-25

The Cut13:50 2-May-25

The Independent13:28 2-May-25

Latin Times13:21 2-May-25

UNILAD12:21 2-May-25

American Journal of Managed Care11:16 2-May-25

American Journal of Managed Care10:45 2-May-25

American Journal of Managed Care09:04 2-May-25

The Mirror08:45 2-May-25

Primetimer08:43 2-May-25

pharmaphorum07:01 2-May-25

view more headlines

12 May 20:29

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

星空传媒

Tirzepatide

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories